CARDIOME PHARMA CORP - COM NO PAR (CRME)

CUSIP: 14159U301

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / COM NO PAR
Total 13F shares
18,618,678
Share change
-867,348
Total reported value
$55,999,161
Price per share
$3.01
Number of holders
29
Value change
-$2,573,813
Number of buys
10
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 14159U301?
CUSIP 14159U301 identifies CRME - CARDIOME PHARMA CORP - COM NO PAR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CARDIOME PHARMA CORP - COM NO PAR (CRME) as of Q1 2017

As of 31 Mar 2017, CARDIOME PHARMA CORP - COM NO PAR (CRME) was held by 29 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,618,678 shares. The largest 10 holders included WESTFIELD CAPITAL MANAGEMENT CO LP, PUTNAM INVESTMENTS LLC, Clough Capital Partners L P, Stonepine Capital Management, LLC, Tamarack Advisers, LP, Rock Springs Capital Management LP, AlphaOne Investment Services, LLC, SABBY MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, and JPMORGAN CHASE & CO. This page lists 29 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.